Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Perspective Therapeutics (CATX) Inventory Average (2016 - 2023)

Perspective Therapeutics' Inventory Average history spans 12 years, with the latest figure at $1.1 million for Q3 2023.

  • For Q3 2023, Inventory Average fell 28.55% year-over-year to $1.1 million; the TTM value through Sep 2023 reached $1.1 million, down 28.55%, while the annual FY2022 figure was $1.4 million, N/A changed from the prior year.
  • Inventory Average for Q3 2023 was $1.1 million at Perspective Therapeutics, down from $1.3 million in the prior quarter.
  • Across five years, Inventory Average topped out at $1.5 million in Q4 2022 and bottomed at $513500.0 in Q1 2019.
  • The 5-year median for Inventory Average is $855500.0 (2021), against an average of $908184.2.
  • The largest annual shift saw Inventory Average surged 62.94% in 2021 before it fell 28.55% in 2023.
  • A 5-year view of Inventory Average shows it stood at $523000.0 in 2019, then increased by 24.86% to $653000.0 in 2020, then soared by 62.94% to $1.1 million in 2021, then soared by 39.19% to $1.5 million in 2022, then dropped by 28.87% to $1.1 million in 2023.
  • Per Business Quant, the three most recent readings for CATX's Inventory Average are $1.1 million (Q3 2023), $1.3 million (Q2 2023), and $1.4 million (Q1 2023).